Should mild cognitive impairment be subtyped?

Current Opinion in Psychiatry

Volumn 24, Issue 3, 2011, Pages 237-242

  Hughes, Tiffany F ^a   Snitz, Beth E ^b   Ganguli, Mary ^a,b,c,d  

^a Department of Psychiatry ^*  (United States)

^b University School of Medicine   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Alzheimer's disease; amnestic mild cognitive impairment; biomarkers; cerebrovascular disease; multiple domain mild cognitive impairment; nonamnestic mild cognitive impairment; single domain mild cognitive impairment

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR DISEASE; DEMENTIA; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; HUMAN; MEMORY; MILD COGNITIVE IMPAIRMENT; PREDICTIVE VALIDITY; PREDICTIVE VALUE;

AGING; COGNITION DISORDERS; HUMANS; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 79955102461     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e328344696b     Document Type: Article

References (45)

1. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56:303-308. (Pubitemid 29120227)
2. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia: meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009; 119:252-265.
3. Farias ST, Mungas D, Reed BR, et al. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol 2009; 66:1151-1157.
4. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991; 41:1006-1009.
5. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment: beyond controversies, towards a consensus - report of the International Working Group on Mild Cognitive Impairment. J Int Med 2004; 256:240-246. (Pubitemid 39222993)
6. Forlenza OV, Chiu E. Mild cognitive impairment: a concept ready to move on? Curr Opin Psychiatry 2008; 21:529-532.
7. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 2003; 160:4-12. (Pubitemid 36042419)
8. He J, Farias S, Martinez O, et al. Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes. Arch Neurol 2009; 66:1393-1399.
9. Duara R, Loewenstein DA, Potter E, et al. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology 2008; 71:1986-1992.
10. Van de Pol L, Verhey F, Frisoni G, et al. White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA Study. J Neurol Neurosurg Psychiatry 2009; 80:1069-1074.
11. Kantarci K, Petersen RC, Przybelski SA, et al. Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes. Arch Neurol 2008; 65:1621-1628.
12. Mosconi L, Tsui WH, Herholz K, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med 2008; 49:390-398. (Pubitemid 351355204)
13. Clerici F, Del Sole A, Chiti A, et al. Differences in hippocampal metabolism between amnestic and nonamnestic MCI subjects: automated FDG-PET image analysis. Q J Nucl Med Mol Imaging 2009; 53:646-657.
14. Pike KE, Savage G, Villemagne VL, et al. Beta-amyloid imaging and memory in nondemented individuals: evidence for preclinical Alzheimer's disease. Brain 2007; 130 (Pt 11):2837-2844. (Pubitemid 350033975)
15. Wolk DA, Price JC, Saxton JA, et al. Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol 2009; 65:557-568.
16. Nordlund A, Rolstad S, Klang O, et al. Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI. J Int Neuropsychol Soc 2008; 14:582-590. (Pubitemid 351935880)
17. Vemuri P, Wiste HJ, Weigand SD, et al. MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology 2009; 73:287-293.
18. Mariani E, Monastero R, Ercolani S, et al. Vascular risk factors in mild cognitive impairment subtypes. Findings from the ReGAl project. Dement GeriatrCogn Disord 2007; 24:448-456.
19. Knopman DS, Roberts RO, Geda YE, et al. Association of prior stroke with cognitive function and cognitive impairment: a population-based study. Arch Neurol 2009; 66:614-619.
20. Reitz C, Tang MX, Manly J, et al. Hypertension and the risk of mild cognitive impairment. Arch Neurol 2007; 64:1734-1740. (Pubitemid 350254935)
21. Bekris LM, Yu C-E, Bird TD, Tsuang DW. Review article: genetics of Alzheimer disease. J Geriatr Psychiatry Neurol 2010; 23:213-227.
22. Haan M, Mayeda ER. Apolipoprotein E genotype and cardiovascular disease in the elderly. Curr Cardiovasc Risk Rep 2010; 4:361-368.
23. Sasaki M, Kodama C, Hidaka S, et al. Prevalence of four subtypes of mild cognitive impairment and APOE in a Japanese community. Int J Geriatr Psychiatry 2009; 24:1119-1126.
24. Fischer P, Jungwirth S, Zehetmayer S, et al. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology 2007; 68:288-291. (Pubitemid 46148341)
25. Norlund A, Rolstad S, Klang O, et al. Two year outcome of MCI subtypes and aetiologies in the Goteborg MCI study. J Neurol Neurosurg Psychiatry 2010; 81:541-546.
26. Palmer K, Backman L, Winblad B, Fratiglioni L Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. Am J Geriatr Psychiatry 2008; 16:603-611.
27. Ganguli M, Snitz BE, Saxton JA, et al. Outcomes of mild cognitive impairment depend on definition: a population study. Arch Neurol (in press).
28. Jak AJ, Bondi MW, Delano-Wood L, et al. Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am J Geriatr Psychiatry 2009; 17:368-375.
29. Matthews FE, Stephan BCM, McKeith IG, et al. Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J Am Geriatr Soc 2008; 56:1424-1433.
30. Ritchie LJ, Tuokko H. Patterns of cognitive decline, conversion rates, and predictive validity for 3 models of MCI. Am J Alzheimers Dis Other Demen 2010; 25:592-603.
31. Diniz BS, Nunes PV, Yassuda MS, et al. Diagnosis of mild cognitive impairment revisited after one year. Preliminary results of a prospective study. Dement Geriatr Cogn Disord 2009; 27:224-231.
32. Forlenza OV, Diniz BS, Nunes PV, et al. Diagnostic transitions in mild cognitive impairment subtypes. Int Psychogeriatr 2009; 21:1088-1095.
33. Bangen KJ, Jak AJ, Schiehser DM, et al. Complex activities of daily living vary by mildcognitive impairmentsub type. J Int Neuropsychol Soc2010;16:630-639.
34. Kim KR, Lee KS, Cheong H-K, et al. Characteristic profiles of instrumental activities of daily living in different subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord 2009; 27:278-285.
35. Teng E, Becker BW, Woo E, et al. Subtle cognitive deficits in instrumental activities of daily living in subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord 2010; 30:189-197.
36. Stephan BCM, Savva GM, Brayne C, et al. Optimizing mild cognitive impairment for discriminating dementia risk in the general older population. Am J Geriatr Psychiatry 2010; 18:662-673.
37. Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol 2009; 66:200-208.
38. Aarsland D, Bronnik K, Williams-Gray C, et al. Mild cognitive impairment in Parkinson's disease: a multicenter pooled analysis. Neurology 2010; 75:1062-1069.
39. Williams-Gray CH, Evans JR, Goris A, et al. The distinct cognitive syndromes of Parkinson's Disease: 5 year follow-up of the CamPaIGN Cohort. Brain 2009; 132:2958-2969.
40. Duff K, Paulsen J, Mills J, et al. Mild cognitive impairment in prediagnosed Huntington's disease. Neurology 2010; 75:500-507.
41. Moorhouse P, Rockwood K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol 2008; 7:246-255. (Pubitemid 351215983)
42. Hachinski V, Costantino I, Petersen RC, et al. National Institute of Neurological Disease and Stroke - Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards. Stroke 2006; 37:2220-2241. (Pubitemid 44337162)
43. Espinosa A, Alegret M, Boada M, et al. Ecological assessment of executive functions in mild cognitive impairment and mild Alzheimer's disease. J Int Neuropsychol Soc 2009; 15:751-757.
44. Jessen F, Wiese B, Bachmann C, et al. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry 2010; 67:414-422.
45. Reisberg B, Gauthier S. Current evidence for subjective cognitive impairment (SCI) as the premild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. Int Psychogeriatr 2008; 20:1 - 16. (Pubitemid 350256071)